Vineet Laboratories Ltd
VINEETLAB
Company Profile
Business description
Vineet Laboratories Ltd Formerly known as Ortin Laboratories Limited, Unit-II is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Isopropyl-beta-D-thiogalactopyranoside and Nitrophenyl phosphate disodium salt among others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, manufacture of Drug Intermediates & Bulk Dugs.
Contact
5-5-160, Malleswari Nilayam, Opposite Vishnu Theatre
Chintalakunta, L.B.Nagar
HyderabadTG500 074
INDT: +91 4024128833
Sector
Basic Materials
Stock type
Cyclical
Industry
Chemicals
Fiscal Year End
31 March 2026
Employees
79
Stocks News & Analysis
stocks
Distribution growth for ASX income play
Cost containment and growing revenue bode well for profit margins.
stocks
We take a different view to market on ASX bloodbath
Sales growth at CSL was lower than expected but streamlining the business has its perks.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,177.40 | 3.60 | 0.04% |
| CAC 40 | 7,973.03 | 6.05 | -0.08% |
| DAX 40 | 24,276.97 | 146.10 | -0.60% |
| Dow JONES (US) | 44,938.31 | 16.04 | 0.04% |
| FTSE 100 | 9,288.14 | 98.92 | 1.08% |
| HKSE | 25,165.94 | 43.04 | 0.17% |
| NASDAQ | 21,172.86 | 142.09 | -0.67% |
| Nikkei 225 | 42,888.55 | 657.74 | -1.51% |
| NZX 50 Index | 13,153.01 | 81.71 | 0.63% |
| S&P 500 | 6,395.78 | 15.59 | -0.24% |
| S&P/ASX 200 | 8,918.00 | 21.80 | 0.25% |
| SSE Composite Index | 3,766.21 | 38.92 | 1.04% |